Download App

Log in to access Online Inquiry
Company Overview More
Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginase inhibitor that has completed Phase 1b clinical trial for the treatment of cystic fibrosis and chronic airway infection; and ATG-037, an orally-bioavailable small molecule inhibitor of CD73, as well as CB-668, an orally administered inhibitor of the enzyme IL4I1. The company has a license agreement with Mars, Inc. to develop and commercialize Symbioscience’s portfolio of arginase inhibitors for use in human healthcare. It also has clinical trial collaboration with Pfizer to evaluate Pfizer’s PARP inhibitor talazoparib and CDK4/6 inhibitor palbociclib, each in combination with telaglenasta. In addition, the company has a collaboration and license agreement with Incyte Corporation for the research, development, and commercialization of INCB001158, a small molecule arginase inhibitor for the treatment of hematology and oncology; and a license agreement with Antengene Corporation Ltd. for the development and commercialization of CB-708. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
CEO: Molineaux Ph.D., Susan M.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

CALA Calithera Biosciences

0.193-0.026-11.95%
Close 05/18 20:00 ET
0.200+0.007+3.63%
Post Mkt Price 05/18 19:22 ET
High
0.219
Open
0.216
Turnover
314.69K
Low
0.193
Pre Close
0.219
Volume
1.54M
Market Cap
18.77M
P/E(TTM)
Loss
52wk High
2.593
Shares
97.24M
P/E(Static)
Loss
52wk Low
0.154
Float Cap
15.94M
Bid/Ask %
-2.91%
Historical High
33.480
Shs Float
82.57M
Volume Ratio
0.18
Historical Low
0.154
Dividend TTM
--
Div Yield TTM
1400
P/B
-6.03
Dividend LFY
--
Div Yield LFY
725388.60%
Turnover Ratio
1.86%
Amplitude
11.86%
Avg Price
0.204
Lot Size
1
Float Cap
15.94M
Bid/Ask %
-2.91%
Historical High
33.480
Shs Float
82.57M
Volume Ratio
0.18
Historical Low
0.154
Dividend TTM
--
P/B
-6.03
Dividend LFY
--
Turnover Ratio
1.86%
Amplitude
11.86%
Avg Price
0.204
Lot Size
1
Price Forecast

No Data

News

Comment